Merkel Cell Carcinoma Treatment Market By Drugs (Chemotherapy (Antimetabolites, Alkylating agents, Antibiotics, Taxanes, Topoisomerase inhibitors) Immunotherapy, Combination Therapies, Others), By Distribution Channel (Hospitals, Oncology research institutes, Ambulatory surgical centres, Retail Pharmacies, Online Pharmacies) and Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

Merkel Cell Carcinoma Treatment Market size was valued at USD 3.38 billion in 2022 and is poised to grow at a CAGR of 3.9% from 2023-29. Merkel cell carcinoma is an uncommon type of skin cancer and is also known as neuroendocrine skin carcinoma or trabecular carcinoma. It occurs due to the abnormal growth of Merkel cells. This cancer has grown and spreads rapidly beyond the skin. Merkel cells are the type of skin neuroendocrine cells as they share some features with hormone making and nerve cells. Merkel cells are found at the base of the epidermis, the top layer of the skin and are very close to nerve endings which helps us to sense touch and light. The report studies market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the market report includes regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the market report include suppliers, manufacturers, marketers, policymakers.

Merkel Cell Carcinoma Treatment Market Key Developments:
  • In 2017 September, Merck KGaA and Pfizer Inc. received market authorization from European Commission for its BAVENCIO (avelumab) for the treatment of metastatic Merkel cell carcinoma.
  • In March 2017, Merck KGaA and Pfizer Inc. received U.S.FDA approval for its BAVENCIO (avelumab) for the treatment of metastatic Merkel cell carcinoma.

Global Merkel Cell Carcinoma Treatment Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

3.9%

Largest Market

North America

Fastest Growing Market

Asia Pacific
Merkel Cell Carcinoma Treatment Market Dynamics

Increasing cases of Merkel cell carcinoma and rising demand for immunotherapy treatment are major factors, expected to drive the growth of the market. Furthermore, growing investments in R&D, developing healthcare infrastructure, are the factors which are propelling the growth of Merkel cell carcinoma treatment market. However, lack of nursing care, adverse effects associated with chemo and immunotherapy drugs, high cost associated with the medicines, restricted adequacy of the medication and stringent regulatory framework are expected to hamper the growth of MCC treatment market.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Global Merkel Cell Carcinoma Treatment Market Segmentation

By Drugs
  • Chemotherapy
  • Immunotherapy
  • Combination Therapies
  • Others
By Distribution Channel
  • Hospitals
  • Oncology research institutes
  • Ambulatory surgical centers
  • Retail Pharmacies
  • Online Pharmacies
By Geography
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Frequently Asked Questions

The merkel cell carcinoma treatment market size was valued at USD 3.38 billion in 2021

The merkel cell carcinoma treatment market key players are Pfizer (U.S) Amgen Inc.(U.S) Merck & Co. Inc.(U.S) BeiGene Ltd.(China) OncoSec Medical Inc.(U.S) Millennium Pharmaceuticals Inc.(U.S)

The merkel cell carcinoma treatment market segments are by drugs and distribution channel

1.Executive Summary
2.Global Merkel Cell Carcinoma Treatment Market Introduction 
2.1.Global Merkel Cell Carcinoma Treatment Market  - Taxonomy
2.2.Global Merkel Cell Carcinoma Treatment Market  - Definitions
2.2.1.Drugs
2.2.2.Distribution Channel
2.2.3.Region
3.Global Merkel Cell Carcinoma Treatment Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Merkel Cell Carcinoma Treatment Market Analysis, 2018 - 2022 and Forecast 2023 - 2029
4.1.  Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Merkel Cell Carcinoma Treatment Market  By Drugs, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
5.1. Chemotherapy
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Immunotherapy
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Combination Therapies
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Others
5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
6.Global Merkel Cell Carcinoma Treatment Market  By Distribution Channel, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
6.1. Hospitals
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Oncology research institutes
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Ambulatory surgical centers
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Retail Pharmacies
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Online Pharmacies
6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
7.Global Merkel Cell Carcinoma Treatment Market  By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
7.1. North America
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Europe
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Asia Pacific (APAC)
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Middle East and Africa (MEA)
7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Latin America
7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
8.North America Merkel Cell Carcinoma Treatment Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
8.1. Drugs Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.1.1.Chemotherapy
8.1.2.Immunotherapy
8.1.3.Combination Therapies
8.1.4.Others
8.2.  Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.2.1.Hospitals
8.2.2.Oncology research institutes
8.2.3.Ambulatory surgical centers
8.2.4.Retail Pharmacies
8.2.5.Online Pharmacies
8.3.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.3.1.United States of America (USA)
8.3.2.Canada
9.Europe Merkel Cell Carcinoma Treatment Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
9.1. Drugs Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Chemotherapy
9.1.2.Immunotherapy
9.1.3.Combination Therapies
9.1.4.Others
9.2.  Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Hospitals
9.2.2.Oncology research institutes
9.2.3.Ambulatory surgical centers
9.2.4.Retail Pharmacies
9.2.5.Online Pharmacies
9.3.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Germany
9.3.2.France
9.3.3.Italy
9.3.4.United Kingdom (UK)
9.3.5.Spain
9.3.6.Rest of EU
 
10.Asia Pacific (APAC) Merkel Cell Carcinoma Treatment Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
10.1. Drugs Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Chemotherapy
10.1.2.Immunotherapy
10.1.3.Combination Therapies
10.1.4.Others
10.2.  Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Hospitals
10.2.2.Oncology research institutes
10.2.3.Ambulatory surgical centers
10.2.4.Retail Pharmacies
10.2.5.Online Pharmacies
10.3.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.China
10.3.2.India
10.3.3.Australia and New Zealand (ANZ)
10.3.4.Japan
10.3.5.Rest of APAC
11.Middle East and Africa (MEA) Merkel Cell Carcinoma Treatment Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
11.1. Drugs Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Chemotherapy
11.1.2.Immunotherapy
11.1.3.Combination Therapies
11.1.4.Others
11.2.  Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Hospitals
11.2.2.Oncology research institutes
11.2.3.Ambulatory surgical centers
11.2.4.Retail Pharmacies
11.2.5.Online Pharmacies
11.3.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.GCC Countries
11.3.2.South Africa
11.3.3.Rest of MEA
12.Latin America Merkel Cell Carcinoma Treatment Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
12.1. Drugs Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Chemotherapy
12.1.2.Immunotherapy
12.1.3.Combination Therapies
12.1.4.Others
12.2.  Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Hospitals
12.2.2.Oncology research institutes
12.2.3.Ambulatory surgical centers
12.2.4.Retail Pharmacies
12.2.5.Online Pharmacies
12.3.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Brazil
12.3.2.Mexico
12.3.3.Rest of LA
13. Competition Landscape
13.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
13.2.1.Pfizer (U.S)
13.2.2.Amgen Inc.(U.S)
13.2.3.Merck & Co. Inc.(U.S)
13.2.4.BeiGene Ltd.(China)
13.2.5.OncoSec Medical Inc.(U.S)
13.2.6.Millennium Pharmaceuticals Inc.(U.S)
13.2.7.Oncovir Inc. (U.S)
13.2.8.Novartis AG (Switzerland)
13.2.9.NantKwest Inc. (U.S)
14. Research Methodology 
15. Appendix and Abbreviations 
  • Pfizer (U.S)
  • Amgen Inc.(U.S)
  • Merck & Co. Inc.(U.S)
  • BeiGene Ltd.(China)
  • OncoSec Medical Inc.(U.S)
  • Millennium Pharmaceuticals Inc.(U.S)
  • Oncovir Inc. (U.S)
  • Novartis AG (Switzerland)
  • NantKwest Inc. (U.S)

Adjacent Markets